Rita Reis Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rita Reis Santos has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Pedro Adragão
Cardiology Department, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
5 shared publicationsPedro Freitas
Cardiology Department, Hospital De Santa Cruz, Centro Hospitalar De Lisboa Ocidental, Carnaxide, Portugal
5 shared publications- Daniel A. Gomes
Cardiology Department, Hospital de Santa Cruz, Unidade Local de Saúde Lisboa Ocidental , Av. Prof. Dr. Reinaldo dos Santos, Carnaxide, Lisboa 2790-134
4 shared publications Mariana Sousa Paiva
Hosp Santa Cruz, Ctr Hosp Lisboa Ocidental, Cardiol Dept, P-2790134 Carnaxide, Portugal
4 shared publications- Marisa Trabulo
Unidade Local de Saúde de Lisboa Ocidental, Portugal
4 shared publications Pedro Carmo
Cardiology Department, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
4 shared publications
Latest Publications
- Open Access
- 25 January 2025
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 44 (5) , 269-275
Safety and effectiveness of pulsed field ablation for pulmonary vein isolation in atrial fibrillation patients: One-year single center experience
- 25 January 2025
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 44 (5) , 269-275
Open AccessSafety and effectiveness of pulsed field ablation for pulmonary vein isolation in atrial fibrillation patients: One-year single center experience
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (2)
Atrial Fibrillation Catheter Ablation: Electroporation Against High-Power Short Duration Radiofrequency
Background Pulmonary vein isolation (PVI) is crucial in treating symptomatic atrial fibrillation (AF). New ablation technologies, such as pulse-field ablation (PFA) and high-power short-duration (HPSD) have emerged in the electrophysiology lab. However, no study has compared the outcomes of these approaches. Objective To compare the efficacy and safety of PFA and HPSD in AF symptomatic patients. Methods Single-centre, retrospective study of consecutive patients undergoing PVI with PFA or HPSD between May and December 2022. Demographic data, procedural data, and AF recurrence beyond the blanking period, were analysed. Comparative analysis between both techniques was performed. A P-value of <0.05 was considered statistically significant. Results A total 101 patients were included (61±11 years, 75% men); 56% of patients had paroxysmal AF and 19% underwent a redo ablation. Forty-five percent of patients underwent HPSD ablation and 55% PFA. Comparing HPSD and PFA, HPSD had a lower fluoroscopy time (5min [IQR 3-7min]vs 13min [IQR 10-16min], p<0.001), but higher procedure time (97min [IQR 75-142]vs 88min [IQR 66-111], p=0.13). Posterior wall isolation (PWI) was performed in 5 (11%) HPSD vs 20 (36%) PFA patients (p=0.004). There was only one case of major complication, a patient with cardiac tamponade following PFA, who was treated with pericardiocentesis. Over 384 (IQR 341 -545) days of follow-up, 76 patients (75%) were in sinus rhythm, while 25% of patients had AF recurrence: 10 PFA patients and 15 HPSD patients (p=0.06). Conclusions Both PFA and HPSD were found to be feasible and safe procedures. PFA resulted in shorter procedure times, and lower AF recurrence rates, mainly when PWI was performed. Although analysis in a real-world scenario is still scarce, both techniques seem to be efficient, with a low AF recurrence rate.
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (2)
Open AccessAtrial Fibrillation Catheter Ablation: Electroporation Against High-Power Short Duration Radiofrequency
Background Pulmonary vein isolation (PVI) is crucial in treating symptomatic atrial fibrillation (AF). New ablation technologies, such as pulse-field ablation (PFA) and high-power short-duration (HPSD) have emerged in the electrophysiology lab. However, no study has compared the outcomes of these approaches. Objective To compare the efficacy and safety of PFA and HPSD in AF symptomatic patients. Methods Single-centre, retrospective study of consecutive patients undergoing PVI with PFA or HPSD between May and December 2022. Demographic data, procedural data, and AF recurrence beyond the blanking period, were analysed. Comparative analysis between both techniques was performed. A P-value of <0.05 was considered statistically significant. Results A total 101 patients were included (61±11 years, 75% men); 56% of patients had paroxysmal AF and 19% underwent a redo ablation. Forty-five percent of patients underwent HPSD ablation and 55% PFA. Comparing HPSD and PFA, HPSD had a lower fluoroscopy time (5min [IQR 3-7min]vs 13min [IQR 10-16min], p<0.001), but higher procedure time (97min [IQR 75-142]vs 88min [IQR 66-111], p=0.13). Posterior wall isolation (PWI) was performed in 5 (11%) HPSD vs 20 (36%) PFA patients (p=0.004). There was only one case of major complication, a patient with cardiac tamponade following PFA, who was treated with pericardiocentesis. Over 384 (IQR 341 -545) days of follow-up, 76 patients (75%) were in sinus rhythm, while 25% of patients had AF recurrence: 10 PFA patients and 15 HPSD patients (p=0.06). Conclusions Both PFA and HPSD were found to be feasible and safe procedures. PFA resulted in shorter procedure times, and lower AF recurrence rates, mainly when PWI was performed. Although analysis in a real-world scenario is still scarce, both techniques seem to be efficient, with a low AF recurrence rate.
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (2) , e20240542
Ablação de Fibrilação Atrial: Eletroporação versus Ablação por Radiofrequência de Alta Potência e Curta Duração
Resumo Fundamento O Isolamento da Veia Pulmonar (IVP) é crucial no tratamento de Fibrilação Atrial (FA). Novas tecnologias de ablação, tais como Ablação por Campo Pulsado (ACP) e ablação por radiofrequência de Alta Potência e Curta duração (HPSD, do inglês high-power short-duration) surgiram no laboratório de eletrofisiologia. No entanto, não há estudos comparando os desfechos dessas abordagens. Objetivo Comparar a eficácia, a segurança da ACP e da ablação por HPSD em pacientes com FA sintomática. Métodos Estudo retrospectivo, unicêntrico, de pacientes consecutivos submetidos ao IPP com ACP ou HPSD entre maio e dezembro de 2022. Foram analisados dados demográficos, dados relacionados ao procedimento, e recorrência de FA durante o seguimento. Foi realizada análise comparativa entre as duas técnicas. Um valor de p <0,05 foi considerado estatisticamente significativo. Resultados Foram incluídos 101 pacientes (61±11 anos, 75% homens); 56% dos pacientes apresentaram FA paroxística e 19% foram submetidos a uma segunda ablação. Quarenta e cinco porcento dos pacientes foram submetidos à ablação por HPSD e 55% à ACP. Na comparação entre a ablação por HPSD e ACP, a primeira técnica apresentou um menor tempo de fluoroscopia [5min (IIQ 3-7min] vs. 13min (IQR 10-16min), p<0,001], porém um tempo de procedimento mais longo [97min (IQR 75-142) vs. 88min (IQR 66-111), p=0,13]. O Isolamento da Parede Posterior (IPP) foi realizado em cinco (11%) dos pacientes submetidos à ablação por HPSD vs. 20 (36%) dos submetidos à ACP (p=0,004). Houve somente um caso de complicação maior, um paciente com tamponamento cardíaco após a ACP, tratado com pericardiocentese. Ao longo do período de acompanhamento [384 (IIQ 341 -545) dias], 76 pacientes (75%) encontravam-se em ritmo sinusal, e 25% dos pacientes sofreram recorrência de FA (10 pacientes no grupo ACP e 15 no grupo HPSD, p=0,06). Conclusões Observou-se que tanto a ACP como a ablação por HPSD é um procedimento viável e seguro. A ACP resultou em tempos mais curtos de procedimento e menores taxas de recorrência de FA, principalmente quando o IPP foi realizado. Embora avaliações no mundo real sejam ainda escassas, ambas as técnicas parecem eficientes, com uma baixa taxa de recorrência de FA.
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (2) , e20240542
Open AccessAblação de Fibrilação Atrial: Eletroporação versus Ablação por Radiofrequência de Alta Potência e Curta Duração
Resumo Fundamento O Isolamento da Veia Pulmonar (IVP) é crucial no tratamento de Fibrilação Atrial (FA). Novas tecnologias de ablação, tais como Ablação por Campo Pulsado (ACP) e ablação por radiofrequência de Alta Potência e Curta duração (HPSD, do inglês high-power short-duration) surgiram no laboratório de eletrofisiologia. No entanto, não há estudos comparando os desfechos dessas abordagens. Objetivo Comparar a eficácia, a segurança da ACP e da ablação por HPSD em pacientes com FA sintomática. Métodos Estudo retrospectivo, unicêntrico, de pacientes consecutivos submetidos ao IPP com ACP ou HPSD entre maio e dezembro de 2022. Foram analisados dados demográficos, dados relacionados ao procedimento, e recorrência de FA durante o seguimento. Foi realizada análise comparativa entre as duas técnicas. Um valor de p <0,05 foi considerado estatisticamente significativo. Resultados Foram incluídos 101 pacientes (61±11 anos, 75% homens); 56% dos pacientes apresentaram FA paroxística e 19% foram submetidos a uma segunda ablação. Quarenta e cinco porcento dos pacientes foram submetidos à ablação por HPSD e 55% à ACP. Na comparação entre a ablação por HPSD e ACP, a primeira técnica apresentou um menor tempo de fluoroscopia [5min (IIQ 3-7min] vs. 13min (IQR 10-16min), p<0,001], porém um tempo de procedimento mais longo [97min (IQR 75-142) vs. 88min (IQR 66-111), p=0,13]. O Isolamento da Parede Posterior (IPP) foi realizado em cinco (11%) dos pacientes submetidos à ablação por HPSD vs. 20 (36%) dos submetidos à ACP (p=0,004). Houve somente um caso de complicação maior, um paciente com tamponamento cardíaco após a ACP, tratado com pericardiocentese. Ao longo do período de acompanhamento [384 (IIQ 341 -545) dias], 76 pacientes (75%) encontravam-se em ritmo sinusal, e 25% dos pacientes sofreram recorrência de FA (10 pacientes no grupo ACP e 15 no grupo HPSD, p=0,06). Conclusões Observou-se que tanto a ACP como a ablação por HPSD é um procedimento viável e seguro. A ACP resultou em tempos mais curtos de procedimento e menores taxas de recorrência de FA, principalmente quando o IPP foi realizado. Embora avaliações no mundo real sejam ainda escassas, ambas as técnicas parecem eficientes, com uma baixa taxa de recorrência de FA.
- Open Access
- 20 November 2024
- Published by Elsevier in Heart Rhythm
- Vol. 5 (11) , 839-841
Ventricular tachycardia: Focal pulsed field electroporation as a rescue therapy
- 20 November 2024
- Published by Elsevier in Heart Rhythm
- Vol. 5 (11) , 839-841
Open AccessVentricular tachycardia: Focal pulsed field electroporation as a rescue therapy
- Open Access
Unveiling Mitochondrial Cardiomyopathy: The Crucial Role of Multiparametric Cardiac Magnetic Resonance
- Open Access
- 3 October 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (10) , 2249
Sex-Specific Insights into Etiology, Diagnosis, Treatment, and Prognosis in Significant Tricuspid Regurgitation: A Narrative Review
In recent decades, a burgeoning interest in tricuspid regurgitation (TR) has been prompted by a heightened awareness of its prevalence and the advent of dedicated percutaneous treatment approaches. Despite considerable understanding of its intricate anatomy and response to varying pressure and loading conditions, the impact of biological sex remains a subject of investigation. While TR typically afflicts more women, significant differences in TR etiology and post-treatment outcomes have not been conclusively established. This narrative review seeks to consolidate the latest evidence concerning sex-related nuances in anatomy, pathophysiology, diagnosis, treatment, and prognosis of significant tricuspid regurgitation. Through synthesizing this information, we aim to provide a comprehensive understanding of how sex may influence the management and prognosis of this condition.
- 3 October 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (10) , 2249
Open AccessSex-Specific Insights into Etiology, Diagnosis, Treatment, and Prognosis in Significant Tricuspid Regurgitation: A Narrative Review
In recent decades, a burgeoning interest in tricuspid regurgitation (TR) has been prompted by a heightened awareness of its prevalence and the advent of dedicated percutaneous treatment approaches. Despite considerable understanding of its intricate anatomy and response to varying pressure and loading conditions, the impact of biological sex remains a subject of investigation. While TR typically afflicts more women, significant differences in TR etiology and post-treatment outcomes have not been conclusively established. This narrative review seeks to consolidate the latest evidence concerning sex-related nuances in anatomy, pathophysiology, diagnosis, treatment, and prognosis of significant tricuspid regurgitation. Through synthesizing this information, we aim to provide a comprehensive understanding of how sex may influence the management and prognosis of this condition.
- Open Access
- 26 March 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Cardiac magnetic resonance patterns of left ventricular remodeling in patients with severe aortic stenosis referred to surgical aortic valve replacement
Left ventricular (LV) hypertrophy is a common finding in patients with severe aortic stenosis (AS). Cardiac magnetic resonance (CMR) is the gold-standard technique to evaluate LV remodeling. Our aim was to assess the prevalence and describe the patterns of LV adaptation in AS patients before and after surgical aortic valve replacement (AVR). Prospective study of 130 consecutive patients (71y [IQR 68–77y], 48% men) with severe AS, referred for surgical AVR. Patterns of LV remodeling were assessed by CMR. Besides normal LV ventricular structure, four other patterns were considered: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, and adverse remodeling. At baseline CMR study: mean LV indexed mass: 81.8 ± 26.7 g/m2; mean end-diastolic LV indexed volume: 85.7 ± 23.1 mL/m2 and median geometric remodeling ratio: 0.96 g/mL [IQR 0.82–1.08 g/mL]. LV hypertrophy occurred in 49% of subjects (concentric 44%; eccentric 5%). Both normal LV structure and concentric remodeling had a prevalence of 25% among the cohort; one patient had an adverse remodeling pattern. Asymmetric LV wall thickening was present in 55% of the patients, with predominant septal involvement. AVR was performed in 119 patients. At 3–6 months after AVR, LV remodeling changed to: normal ventricular geometry in 60%, concentric remodeling in 27%, concentric hypertrophy in 10%, eccentric hypertrophy in 3% and adverse remodeling (one patient). Indexes of AS severity, LV systolic and diastolic function and NT-proBNP were significantly different among the distinct patterns of remodeling. Several distinct patterns of LV remodelling beyond concentric hypertrophy occur in patients with classical severe AS. Asymmetric hypertrophy is a common finding and LV response after AVR is diverse.
- 26 March 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open AccessCardiac magnetic resonance patterns of left ventricular remodeling in patients with severe aortic stenosis referred to surgical aortic valve replacement
Left ventricular (LV) hypertrophy is a common finding in patients with severe aortic stenosis (AS). Cardiac magnetic resonance (CMR) is the gold-standard technique to evaluate LV remodeling. Our aim was to assess the prevalence and describe the patterns of LV adaptation in AS patients before and after surgical aortic valve replacement (AVR). Prospective study of 130 consecutive patients (71y [IQR 68–77y], 48% men) with severe AS, referred for surgical AVR. Patterns of LV remodeling were assessed by CMR. Besides normal LV ventricular structure, four other patterns were considered: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, and adverse remodeling. At baseline CMR study: mean LV indexed mass: 81.8 ± 26.7 g/m2; mean end-diastolic LV indexed volume: 85.7 ± 23.1 mL/m2 and median geometric remodeling ratio: 0.96 g/mL [IQR 0.82–1.08 g/mL]. LV hypertrophy occurred in 49% of subjects (concentric 44%; eccentric 5%). Both normal LV structure and concentric remodeling had a prevalence of 25% among the cohort; one patient had an adverse remodeling pattern. Asymmetric LV wall thickening was present in 55% of the patients, with predominant septal involvement. AVR was performed in 119 patients. At 3–6 months after AVR, LV remodeling changed to: normal ventricular geometry in 60%, concentric remodeling in 27%, concentric hypertrophy in 10%, eccentric hypertrophy in 3% and adverse remodeling (one patient). Indexes of AS severity, LV systolic and diastolic function and NT-proBNP were significantly different among the distinct patterns of remodeling. Several distinct patterns of LV remodelling beyond concentric hypertrophy occur in patients with classical severe AS. Asymmetric hypertrophy is a common finding and LV response after AVR is diverse.
- Open Access
- 4 March 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (1) , e20230242
Atingimento das Metas de Colesterol LDL em Pacientes com Histórico de Infarto Agudo do Miocárdio: Estudo Transversal do Mundo Real
Resumo Fundamento: As diretrizes da Sociedade Europeia de Cardiologia recomendam um nível de colesterol LDL (LDL-C) < 55 mg/dL para pacientes com doença cardiovascular estabelecida. Embora a fórmula de Friedewald ainda seja amplamente utilizada para estimar o LDL-C, a fórmula mais recente de Martin-Hopkins mostrou maior precisão. Objetivos: Nosso objetivo foi avaliar: A) a proporção de pacientes que atingiram a meta de LDL-C e as terapias utilizadas em um centro terciário; B) o impacto da utilização do método de Martin-Hopkins
- 4 March 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (1) , e20230242
Open AccessAtingimento das Metas de Colesterol LDL em Pacientes com Histórico de Infarto Agudo do Miocárdio: Estudo Transversal do Mundo Real
Resumo Fundamento: As diretrizes da Sociedade Europeia de Cardiologia recomendam um nível de colesterol LDL (LDL-C) < 55 mg/dL para pacientes com doença cardiovascular estabelecida. Embora a fórmula de Friedewald ainda seja amplamente utilizada para estimar o LDL-C, a fórmula mais recente de Martin-Hopkins mostrou maior precisão. Objetivos: Nosso objetivo foi avaliar: A) a proporção de pacientes que atingiram a meta de LDL-C e as terapias utilizadas em um centro terciário; B) o impacto da utilização do método de Martin-Hopkins
- Open Access
- 22 January 2024
- Published by Elsevier in Heart Rhythm
- Vol. 5 (1) , 60-62
Sinus rhythm restoration after atrial fibrillation plus dual-loop biatrial flutter catheter ablation
- 22 January 2024
- Published by Elsevier in Heart Rhythm
- Vol. 5 (1) , 60-62
Open AccessSinus rhythm restoration after atrial fibrillation plus dual-loop biatrial flutter catheter ablation
- Open Access
- 21 December 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (1) , ytae022
When the cardiac magnetic resonance rescues the surgeon: an unusual clinical case of a right atrial myxoma and a post-operative pseudomass
A 72-year-old woman with a past medical history of hypertension and dyslipidaemia was referred to cardiac surgery consultation because of an asymptomatic right atrial mass detected on a routine transthoracic echocardiogram (TTE) (Figure 1A, Supplementary material online , Videos S1, S2 and S4).
- 21 December 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (1) , ytae022
Open AccessWhen the cardiac magnetic resonance rescues the surgeon: an unusual clinical case of a right atrial myxoma and a post-operative pseudomass
A 72-year-old woman with a past medical history of hypertension and dyslipidaemia was referred to cardiac surgery consultation because of an asymptomatic right atrial mass detected on a routine transthoracic echocardiogram (TTE) (Figure 1A, Supplementary material online , Videos S1, S2 and S4).